IGCCCG Prognostic Group (Metastatic Germ Cell Cancer)
IGCCCG Prognostic Group (Metastatic Germ Cell Cancer) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
Open the IGCCCG Prognostic Group (Metastatic Germ Cell Cancer) → Runs in your browser. No signup, no tracking.
What this is
IGCCCG Prognostic Group (Metastatic Germ Cell Cancer) is one of 230 deterministic tools in Sophie Well's Clinical Scoring & Risk group. IGCCCG Prognostic Group (Metastatic Germ Cell Cancer) - a deterministic tool in Sophie Well's Clinical Scoring & Risk group.
When to use it
Use this tool when you need a quick, citable reference. Every calculation runs entirely in your browser - no inputs leave your device, no account is required, no AI is involved. The site enforces a strict Content Security Policy and ships no analytics or third-party CDN.
References
International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol. 1997;15(2):594-603. Updated outcomes: Gillessen S, et al. J Clin Oncol. 2021;39(14):1563-1574. Read the source ↗
Worked example: IGCCCG intermediate prognosis, nonseminoma.
Sophie Well is a reference and educational tool. Not medical, legal, or financial advice. Does not replace clinician judgment, professional billing review, or legal counsel.